LSX’s Investival Showcase connects life science corporates to global capital and partners. The event is an international showcase of early, growth stage and public life science and health technology companies, the company showcases will highlight and promote the most exciting and innovative biotech, medtech, health technology and consumer health companies across Europe and beyond.
In 2021, Investival is delivered as a hybrid event, blending the best of both virtual and physical. At the online experience (8-15th November) you will hear from, connect, network and schedule 1:1 video meetings with global investors, corporates and strategic partners. A day of physical 1:1s, held at the Waldorf Hilton Hotel London (15th November), provides an in-person day of 1:1 meetings and an exclusive networking function for executives.
Investival Showcase continues its exclusive partnership with global investment bank Jefferies, running the days before the Jefferies London Healthcare Conference.
Mogrify® has developed a proprietary suite of platform that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems 2020). Mogrify is applying its proprietary and award-winning platforms to engineer a renewable and scalable source of cell types that exhibit efficacy and safety profiles necessary to transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies for indications of high unmet clinical need in hematological, immunological, ophthalmological and other disease areas.